Hypertension after pediatric cardiac transplantation: detection, etiology, implications and management.
作者： S. Lucy Roche , John J. O’Sullivan , Paul F. Kantor
DOI: 10.1111/J.1399-3046.2009.01205.X
关键词:
摘要: While it may rescue children with end-stage heart failure from impending catastrophe, cardiac transplantation leaves 50-70% of pediatric recipients new-onset hypertension. Given the unique vulnerability and kidneys in these children, we can expect long-term uncontrolled hypertension to shorten both graft patient survival. In this review discuss multi-factorial etiology post-transplant hypertension, highlighting current uncertainties emphasizing mechanisms specific recipients. We consider optimal means monitoring BP particular, advantages 24 h-ABP over intermittent clinic measurements. also treatment after transplantation, drawing attention cautions appropriate when prescribing antihypertensive agents circumstances.
sci-hub.se 参考文章(122)
Feras M. Bader, Mary E. Hagan, Jason A. Crompton, Edward M. Gilbert, The Effect of β-Blocker Use on Cyclosporine Level in Cardiac Transplant Recipients Journal of Heart and Lung Transplantation. ,vol. 24, pp. 2144- 2147 ,(2005) , 10.1016/J.HEALUN.2005.05.002
Susan C. Brozena, Maryl R. Johnson, Hector Ventura, Robert Hobbs, Leslie Miller, Maria Teresa Olivari, Barry Clemson, Robert Bourge, Rebecca Quigg, Roger M. Mills, David Naftel, Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation Results of a prospective, randomized multicenter trial Journal of the American College of Cardiology. ,vol. 27, pp. 1707- 1712 ,(1996) , 10.1016/0735-1097(96)00057-5
G.K. Oriji, H.R. Keiser, Cyclosporine A-induced contractions and prostacyclin release are maintained by extracellular calcium in rat aortic rings: role of protein kinase C Prostaglandins Leukotrienes and Essential Fatty Acids. ,vol. 56, pp. 151- 156 ,(1997) , 10.1016/S0952-3278(97)90512-3
V.T. Kotsis, S.V. Stabouli, V.Ch. Pitiriga, J.P. Lekakis, I.N. Nanas, S.T. Toumanidis, N.A. Zakopoulos, Impact of cardiac transplantation in 24 hours circadian blood pressure and heart rate profile. Transplantation proceedings. ,vol. 37, pp. 2244- 2246 ,(2005) , 10.1016/J.TRANSPROCEED.2005.03.087
Harvey Cushing, The Basophil Adenomas of the Pituitary Body and Their Clinical Manifestations (Pituitary Basophilism)1 Obesity Research. ,vol. 2, pp. 486- 508 ,(1994) , 10.1002/J.1550-8528.1994.TB00097.X
Jonathan M. Sorof, Ronald J. Portman, White coat hypertension in children with elevated casual blood pressure The Journal of Pediatrics. ,vol. 137, pp. 493- 497 ,(2000) , 10.1067/MPD.2000.108394
E. Schwertfeger, J. Wehrens, V. Oberhauser, A. Katzenwadel, L. C. Rump, Contractile effects of tacrolimus in human and rat isolated renal arteries. Journal of Autonomic Pharmacology. ,vol. 21, pp. 205- 210 ,(2001) , 10.1046/J.1365-2680.2001.00228.X
Giuseppe Mancia, Alberto Zanchetti, Enrico Agebiti-Rosei, Giuseppe Benemio, Raffaele De Cesaris, Roberto Fogari, Achille Pessino, Carlo Porcellati, Antonio Salvetti, Bruno Trimarco, Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy Circulation. ,vol. 95, pp. 1464- 1470 ,(1997) , 10.1161/01.CIR.95.6.1464
Richard Trompeter, Guido Filler, Nicholas J.A. Webb, Alan R. Watson, David V. Milford, Gunnar Tyden, Ryszard Grenda, Jan Janda, David Hughes, Jochen H.H. Ehrich, Bernd Klare, Graziella Zacchello, Inge Bjorn Brekke, Mary McGraw, Ferenc Perner, Lucian Ghio, Egon Balzar, Styrbjörn Friman, Rosanna Gusmano, Jochen Stolpe, Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatric Nephrology. ,vol. 17, pp. 141- 149 ,(2002) , 10.1007/S00467-001-0795-9
G.V.R. Prasad, M. Huang, M.M. Nash, J.S. Zaltzman, Role of dietary salt intake in posttransplant hypertension with tacrolimus-based immunosuppression. International Congress on Immunosuppression. ,vol. 37, pp. 1896- 1897 ,(2005) , 10.1016/J.TRANSPROCEED.2005.04.002